Prezent AI Introduces Prezent Vivo to Bridge Science, Data, and Communication

Startup Prezent AI is positioning a new solution, Prezent Vivo, to operate within the life sciences communication ecosystem. The move is notable not for its use of artificial intelligence, but for its explicit fusion of AI with human oversight, a direct acknowledgment of the precision required in the field. (Source) This launch occurs against a backdrop where, by 2025, a quarter of organizations in the life sciences sector had already integrated artificial intelligence at scale, indicating a clear trajectory of adoption.

Prezent Vivo is designed to combine a customized large language model (LLM) with subject matter experts. According to Prezent AI, this platform will deliver AI-powered communication for materials such as congress posters, data visualization, and scientific documents. Rajat Mishra, CEO of Prezent, frames the strategy directly, stating that the future of Life Sciences communication is a "fusion of AI and experts." This is not a bet on pure automation, but on a hybrid model where technology augments specialized human knowledge.

The strategic commitment to this hybrid approach is underscored by the appointment of Francine Carrick as President of Prezent Vivo. Carrick’s background is in medical communications, not pure technology. Her experience includes nearly seven years at Envision Pharma Group before a role at BCB Group in 2024. Placing a leader with this specific domain expertise at the helm of an AI-centric product signals Prezent AI’s core thesis: in highly regulated and specialized domains, the credibility of the human expert is as critical as the capability of the underlying model. The platform’s value proposition is therefore not just the LLM, but the integrated system of technology and validated expertise.

This structure directly addresses the inherent tension in applying generative AI to scientific communication. The goal is to leverage the scale of AI for producing deliverables while using human experts to ensure the nuance, context, and accuracy required by the life sciences industry. Prezent AI is betting that organizations in the sector will not adopt generic AI tools for critical communications, but will pay for a service that embeds the necessary guardrails and domain knowledge from the outset.

The open question for Prezent AI and its Prezent Vivo solution centers on the operational model. A pure technology platform scales differently than one reliant on subject matter experts. The success of this initiative will depend on how effectively Prezent AI can scale the human component of its "AI and experts" fusion. Managing the quality, availability, and cost of that expertise will be the determining factor in whether this hybrid model can deliver on its promise of both speed and precision.